Table 1 Clinicopathological characteristics for the cohort.
Characteristic | |
|---|---|
Patients, N | 187 |
Age at RP (years) | |
Median (range) | 64.2 (48.3–76.8) |
PSA at diagnosis (ng/ml) | |
Median (range) | 12.1 (2–61) |
Pathological Gleason score | |
< 7, N (%) | 67 (35.8) |
= 7, N (%) | 88 (47.1) |
> 7, N (%) | 32 (17.1) |
Pathological T-stage | |
T2a, N (%) | 23 (12.3) |
T2b, N (%) | 17 (9.1) |
T2c, N (%) | 80 (42.8) |
T3a, N (%) | 46 (24.6) |
T3b, N (%) | 21 (11.2) |
Surgical margin status | |
0, N (%) | 125 (66.9) |
1, N (%) | 62 (33.1) |
Biochemical recurrence status | |
BCR, N (%) | 96 (51.3) |
BCR-free, N (%) | 91 (48.7) |
Total follow-up (months) | |
Median (range) | 134.2 (12.1–249.3) |
